Target M0035434060Recalls & reported problems
Stryker Corporation · Helical Ultra Detachable Coil · Class 2 · Implant
All models of TARGET (114)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04546540676108), received between Mar 12, 2019 and Aug 27, 2019 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Break1
- Fracture1
- Premature Separation1
Patient problems
- No Consequences Or Impact To Patient1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 27, 2019Break; Fracture; Break; Fracture
IT WAS REPORTED THAT THE DELIVERY WIRE OF THE COIL WAS BROKEN WHEN INSERTED INTO THE MICROCATHETER. NO PATIENT CONSEQUENCES WERE REPORTED DUE TO THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8935763 ↗InjuryMar 12, 2019Premature Separation; Premature Separation
IT WAS REPORTED THAT THE SUBJECT COIL WAS USED DURING COIL EMBOLIZATION PROCEDURE FOR ANEURYSM LOCATED IN THE INTERNAL CAROTID ARTERY (ICA). THE PHYSICIAN WAS ABLE TO INTRODUCER THE COIL INTO THE PATIENT¿S ANATOMY; HOWEVER, THE COIL PREMATURELY DETACHED BEFORE REACHING THE TARGET LESION. TWO STENTS WERE IMPLANTED TO SECURE THE SUBJECT COIL IN PLACE AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO KNOW CLINICAL CONSEQUENCES WAS REPORTED TO THE PATIENT DUE TO THIS EVENT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8414396 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page